Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Can we develop ethically universal embryonic stem-cell lines?

Abstract

Human embryonic stem-cell (hESC) research faces opposition from those who object to the destruction of human embryos. Over the past few years, a series of new approaches have been proposed for deriving hESC lines without injuring a living embryo. Each of these presents scientific challenges and raises ethical and political questions. Do any of these methods have the potential to provide a source of hESCs that will be acceptable to those who oppose the current approaches?

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Approaches to generating human embryonic stem cells (hESCs).

References

  1. Liao, S. M. Rescuing human embryonic stem cell research: the blastocyst transfer method. Am. J. Bioeth. 5, 8–16, (2005).

    Article  PubMed  Google Scholar 

  2. Walters, L. Human embryonic stem cell research: an intercultural perspective. Kennedy Inst. Ethics J. 14, 3–38 (2004).

    Article  PubMed  Google Scholar 

  3. European Parliament. €54 billion boost for EU scientific research 2007–2013 [online], (2006).

  4. Kaljuvee, A. Blind faith vs. science. Ego (9 August 2006) [online], (2006).

    Google Scholar 

  5. OECD Health Division. Expenditure on health-related functions: Public expenditure on health R&D, 10 October 2006. [online], (2006).

  6. Green, R. M. Benefiting from 'evil': an incipient moral problem in human stem cell research. Bioethics 16, 544–556 (2002).

    Article  PubMed  Google Scholar 

  7. Williams, C. The Campaign For Ethical Vaccines: Alternatives to vaccines made from aborted babies [online], (2002).

    Google Scholar 

  8. Sgreccia, E. Moral reflections on vaccines prepared from cells derived from aborted human fetuses. Pontificia Academia Pro Vita (Pontifical Academy for Life), Vatican City (9 June 2005) [online], (2005).

    Google Scholar 

  9. Wagers, A. & Weissman, I. L. Plasticity of adult stem cells. Cell 116, 639–648 (2004).

    CAS  PubMed  Google Scholar 

  10. Schwartz, R. S. The politics and promise of stem-cell research. N. Eng. J. Med. 355, 1189–1191 (2006).

    CAS  Article  Google Scholar 

  11. De Coppi, P. et al. Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnol. 25, 100–106 (2007).

    CAS  Article  Google Scholar 

  12. Hurlbut, W. B. Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells. Commissioned working paper for the President's Council on Bioethics December 2004 meeting [online], (2004).

    Google Scholar 

  13. Hurlbut, W. B. Statement of Dr. Hurlbut in President's Council on Bioethics, Human Cloning and Human Dignity 267–276 [online], (2002).

    Google Scholar 

  14. Meissner, A. & Jaenisch, R. Generation of pluripotent NT-ES cells from cloned Cdx2 deficient blastocysts. Nature 439, 212–215 (2006).

    CAS  Article  PubMed  Google Scholar 

  15. Kiessling, A. A. In the stem-cell debate, new concepts need new words. Nature 413, 453 (2001).

    CAS  Article  PubMed  Google Scholar 

  16. Melton, D. A., Daley, G. Q. & Jennings, C. G. Altered nuclear transfer in stem-cell research — a flawed proposal. N. Eng. J Med. 351, 2791–2792 (2004).

    CAS  Article  Google Scholar 

  17. Kass, L. The wisdom of repugnance: why we should ban the cloning of humans New Repub. 216, 17–26 (1997).

    PubMed  Google Scholar 

  18. United Nations. Declaration on Human Cloning. August 3, 2005. [online], (2005).

  19. Crockin, S. Challenges of stem-cell research. Boston Globe (12 December 2006).

    Google Scholar 

  20. Kim, K. et al. Histocompatible embryonic stem cells by parthenogenesis. Science 315, 482–486 (2007).

    CAS  Article  PubMed  Google Scholar 

  21. Vrana, K. E. et al. Nonhuman primate parthenogenetic stem cells. Proc. Natl Acad. Sci. USA 100, 11911–11916 (2003).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. Landry, D. W. & Zucker, H. A. Embryonic death and the creation of human embryonic stem cells. J. Clin. Invest. 114, 1184–1186 (2004).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. Munné, S. et al. Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fert. Steril. 84, 1328–1334 (2005).

    Article  Google Scholar 

  24. Verlinsky, Y. et al. Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil. Steril. 82, 292–294, (2004).

    Article  PubMed  Google Scholar 

  25. Chung, Y. et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439, 216–219 (2006).

    CAS  Article  PubMed  Google Scholar 

  26. Klimanskaya, I., Chung, Y., Becker, S., Lu, S. & Lanza, R. Human embryonic stem cell lines derived from single blastomeres. Nature 444, 481–485 (2006).

    CAS  Article  PubMed  Google Scholar 

  27. Simpson, J. L. Blastomeres and stem cells. Nature 444, 433–435 (2006).

    Article  Google Scholar 

  28. Code of Federal Regulations §46. 203 (b). [online], (2005).

  29. Code of Federal Regulations §46. 406.[online], (2005)

  30. Deb, K., Sivaguru, M., Yong, H. Y. & Roberts, R. M. Cdx2 gene expression and trophectoderm lineage specification in mouse embryos. Science 311, 992–996 (2006).

    CAS  Article  PubMed  Google Scholar 

  31. Piotrowska-Nitsche, K., Perea-Gomez, A., Haraguchi, S. & Zernicka-Goetz, Z. Four-cell stage mouse blastomeres have different developmental properties. Development 132, 479–490 (2005).

    CAS  Article  PubMed  Google Scholar 

  32. Balanced Budget Downpayment Act I of 1996, Pub. L. No. 104–99, §128, 110 Stat. 26, 34. [online], (1996).

  33. Hudson, K. L. Preimplantation genetic diagnosis: public policy and public attitudes. Fertil. Steril. 85, 1638–1645 (2006).

    Article  PubMed  Google Scholar 

  34. Davis, D. S. The puzzle of IVF. Houst. J. Health Law Policy 6, 275–296 (2006).

    Google Scholar 

  35. Alberio, R., Campbell, K. H. & Johnson, A. D. Focus on stem cells: Reprogramming somatic cells into stem cells. Reproduction 132, 709–720 (2006).

    CAS  Article  PubMed  Google Scholar 

  36. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

    CAS  Article  PubMed  Google Scholar 

  37. Chief Medical Officer's Expert Group (UK). Stem Cell Research: Medical Progress with Responsibility, Department of Health, June 2000. [online], (2007).

Download references

Acknowledgements

I dedicate this to the memory of J. Cohen. His commitment to ethics at Dartmouth College made possible the research that underlies this discussion.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Related links

Related links

FURTHER INFORMATION

Advanced Cell Technology

Harvard Stem Cell Institute

Ronald M. Green's homepage

Glossary

Adult stem cell

An undifferentiated cell that exists among differentiated cells in a tissue or organ, and that can renew itself and differentiate to yield the main specialized cell types of that tissue or organ.

Aneuploidy

The presence of extra copies, or fewer copies, of some chromosomes.

Blastocyst

A preimplantation embryo that contains a fluid-filled cavity called a blastocoel.

Blastomere

A cell that results from embryonic cleavage.

Inner cell mass

A small group of undifferentiated cells that are present in the blastocyst.

Major histocompatibility complex

A group of genes in mammals that help determine the histocompatibility antigens that are found on cell surfaces and that modulate immune responses.

Paternal imprinting

The selective switching on or off of genes caused by factors that are inherited from the paternal chromosomes.

Pluripotent

Able to give rise to a range of, but not all, cell lineages (usually all fetal lineages and a subset of extraembryonic lineages).

Somatic-cell nuclear transfer

The process by which the nucleus from an adult cell is transferred into a previously enucleated egg cell; the reconstructed oocyte is then activated, which initiates subsequent development.

Totipotency

The capacity of an undifferentiated cell to develop into any type of cell.

Trophoblast

An extraembryonic lineage that is derived from the trophectoderm of the blastocyst, which gives rise to the fetal portion of the placenta.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Green, R. Can we develop ethically universal embryonic stem-cell lines?. Nat Rev Genet 8, 480–485 (2007). https://doi.org/10.1038/nrg2066

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrg2066

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing